Possible anti-metastatic eVect of Iloprost in a patient with systemic sclerosis with lung cancer: A case study

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1437-1441

  Pehlivan, Yavuz ^a   Turkbeyler, Ibrahim Halil ^a   Balakan, Ozan ^b   Sevinc, Alper ^b   Yilmaz, Mustafa ^b   Bakir, Kemal ^a   Onat, Ahmet Mesut ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b School of Medicine   (Turkey)

Author keywords

Anti metastatic activity; Inhaled iloprost; Lung adenocarcinoma; Prostacyclin analogue; Pulmonary arterial hypertension; Systemic Sclerosis

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; ILOPROST;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; COUGHING; CYANOSIS; DIAGNOSTIC IMAGING; DYSPNEA; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG FIBROSIS; LYMPH NODE DISSECTION; METASTASIS INHIBITION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; WEIGHT REDUCTION;

ADENOCARCINOMA; ADMINISTRATION, INHALATION; ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; BIOPSY; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84863623246     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1848-4     Document Type: Article

References (19)

1. Gilliland BC (2005) Systemic sclerosis and related disorders. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds) Harrison principles of internal medicine, 6th edn. New York, Mc Graw-Hill, pp 1979-1990
2. Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460-464
3. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106-111
4. Goldsmith DR, WagstaV A (2004) Inhaled iloprost in primary pulmonary hypertension. Drugs 64:763-773
5. Scott JP, Higenbottam T, Wallwork J (1990) The acute eVect of synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pract 44:231-234
6. Black CM (1995) The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The parkes weber lecture. J R Coll Physicians Lond 29:119-130
7. Siau K, Laversuch CJ, Creamer P, O'Rourke KP (2010) Malignancy in scleroderma patients from south west England: a population-based cohort study. Rheumatol Int. 8. [Epub ahead of print]
8. Chatterjee S, Dombi GW, Severson RK, Mayes MD (2005) Risk of malignancy in scleroderma. A population-based cohort study. Arthritis Rheum 52:2415-2424
9. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665
10. Belch JJ (1987) EVect of iloprost (ZK 36374) on white cell behaviour. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analogue iloprost. Springer-Verlang, Berlin-Heidelberg, pp 97-102
11. Stürzebecher CS (1987) EVects of iloprost on platelet activation in vitro. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analogue iloprost. Springer, Berlin-Heidelberg, pp 39-45
12. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr, Steen VD, Varga J, Jimenes S, Mayes M (1994) Inrtavenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sklerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 120:199-206
13. Gasic GJ (1984) Role of plasma, platelets and endothelial cells in tumour metastasis. Cancer Metastasis Rev 3:99-116
14. Honn KV, Cicone B, SkoV A (1981) Prostacyclin: a potent antimetastatic agent. Science 212:1270-1272
15. Sava G, Perisin L, Zorzet S, Piccini P, Giraldi T (1989) Antimeta-static action of the prostacyclin anologue Iloprost in the Mouse. Clinical and Experimental Meastasis 7:671-678
16. Schirner M, Schneider MR (1991) Cicaprost inhibits metastases of animal tumours. Prostaglandins 42:451-461
17. Menter DG, Onoda JM, Taylor JD, Honn KV (1984) EVect of prostacyclin on tumour cell-induced platelet aggregation. Cancer Res 44:450-456
18. Tang DG, Grossi IM, Tang KQ, Diglio CA, Honn KV (1995) Inhibition of TPA and 12(S)-HETE-stimulated tumour cell adhesion by prostacyclin and its stable analogs: rationale for their antimeta-static eVects. Int J Cancer 60:418-425
19. Schneider MR, Schillinger E, Schirner M, Skuballa W, Stürzebecher S, Witt W (1991) EVects of prostacyclin analogues in in vivo tumour models. Adv Prostaglandin Thromboxane Leukot Res 21:901-908